Oklahoma · 2026 Regular Session · Bill

HB 3834: Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; effective date.

Enacted Last action May 12, 2026: Approved by Governor 05/12/2026

Plain-language summary

HB 3834 is a bill introduced in the Oklahoma House on February 2, 2026. According to its official title, it concerns: Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; effective date. Primary sponsor: Stan May (Republican), Avery Frix (Republican). Most recent recorded action (May 12, 2026): Approved by Governor 05/12/2026.

Sponsors

Primary sponsors: Stan May (Republican); Avery Frix (Republican).